These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8565447)

  • 21. Schneider's first-rank symptoms have neither diagnostic value for schizophrenia nor higher clinical validity than other delusions and hallucinations in psychotic disorders.
    Peralta V; Cuesta MJ
    Psychol Med; 2023 Apr; 53(6):2708-2711. PubMed ID: 32943125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotic symptoms in pediatric bipolar disorder.
    Pavuluri MN; Herbener ES; Sweeney JA
    J Affect Disord; 2004 May; 80(1):19-28. PubMed ID: 15094254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
    Shelly J; Uhlmann A; Sinclair H; Howells FM; Sibeko G; Wilson D; Stein DJ; Temmingh H
    Psychopathology; 2016; 49(6):429-435. PubMed ID: 27926911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-rank symptoms in the postacute schizophrenic: a follow-up study.
    Silverstein ML; Harrow M
    Am J Psychiatry; 1978 Dec; 135(12):1481-6. PubMed ID: 717561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).
    Haddock G; McCarron J; Tarrier N; Faragher EB
    Psychol Med; 1999 Jul; 29(4):879-89. PubMed ID: 10473315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affective disorders and psychosis in youth.
    Carlson GA
    Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):569-80. PubMed ID: 24012074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of nine systems to diagnose schizophrenia.
    Stephens JH; Astrup C; Carpenter WT; Shaffer JW; Goldberg J
    Psychiatry Res; 1982 Apr; 6(2):127-43. PubMed ID: 6953455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bizarre delusions and DSM-IV schizophrenia.
    Nakaya M; Kusumoto K; Okada T; Ohmori K
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):391-5. PubMed ID: 12109956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Voce A; McKetin R; Burns R; Castle D; Calabria B
    Psychiatry Res; 2018 Jul; 265():19-24. PubMed ID: 29680513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strauss (1969) revisited: a psychosis continuum in the general population?
    van Os J; Hanssen M; Bijl RV; Ravelli A
    Schizophr Res; 2000 Sep; 45(1-2):11-20. PubMed ID: 10978868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of depressive episodes with psychotic features in the general population.
    Ohayon MM; Schatzberg AF
    Am J Psychiatry; 2002 Nov; 159(11):1855-61. PubMed ID: 12411219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric evaluation of the Psychotic Symptom Rating Scales.
    Kronmüller KT; von Bock A; Grupe S; Büche L; Gentner NC; Rückl S; Marx J; Joest K; Kaiser S; Vedder H; Mundt C
    Compr Psychiatry; 2011; 52(1):102-8. PubMed ID: 21220071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schneider's First Rank Symptoms: an international and interethnic comparative study.
    Chandrasena R
    Acta Psychiatr Scand; 1987 Nov; 76(5):574-8. PubMed ID: 3434330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder.
    Rosen C; Grossman LS; Harrow M; Bonner-Jackson A; Faull R
    Compr Psychiatry; 2011; 52(2):126-31. PubMed ID: 21295217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study.
    Ochoa S; Haro JM; Torres JV; Pinto-Meza A; Palacín C; Bernal M; Brugha T; Prat B; Usall J; Alonso J; Autonell J
    Schizophr Res; 2008 Jul; 102(1-3):261-9. PubMed ID: 18495432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Disturbance and the Bizarre: On Incomprehensibility in Schizophrenic Delusions.
    Sass LA; Byrom G
    Psychopathology; 2015; 48(5):293-300. PubMed ID: 26346263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is bizarre in bizarre delusions? A critical review.
    Cermolacce M; Sass L; Parnas J
    Schizophr Bull; 2010 Jul; 36(4):667-79. PubMed ID: 20142381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coping with delusions in schizophrenia and affective disorder with psychotic symptoms: the relationship between coping strategies and dimensions of delusion.
    Rückl S; Gentner NC; Büche L; Backenstrass M; Barthel A; Vedder H; Bürgy M; Kronmüller KT
    Psychopathology; 2015; 48(1):11-7. PubMed ID: 25227592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotic patients with unclear diagnoses. A descriptive analysis.
    Fennig S; Bromet EJ; Craig T; Jandorf L; Schwartz JE
    J Nerv Ment Dis; 1995 Apr; 183(4):207-13. PubMed ID: 7714509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.